Patents by Inventor Karsten Buschard

Karsten Buschard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110111023
    Abstract: The invention herein is related to intranasal or other mucosal administration of gliadin, or parts thereof, to prevent the development of type 1 diabetes. This environmental antigen, which may have etiological role in the development of diabetes in genetically predisposed individuals, has been successfully applied in the prevention of disease.
    Type: Application
    Filed: September 10, 2008
    Publication date: May 12, 2011
    Applicant: KOBENHAVNS UNIVERSITET
    Inventors: Karsten Buschard, David Funda, Petra Fundova, Axel Kornerup Hansen
  • Patent number: 6908904
    Abstract: A method for treatment of a diabetic condition, wherein a therapeutically effective amount of at least one isoform of sulfatide is administered to a patient, wherein said at least one isoform of sulfatide upon administration to the patient affects the sulfatide metabolism in such a way that it results in an increased amount of sulfatide. Also the use of at least one isoform of sulfatide for the production of a pharmaceutical preparation for treatment of a diabetic condition is disclosed. Said isoform is preferably an isoform with 8-24 carbon atoms in the fatty acid chain, more preferably 12, 14, 16 or 18 carbon atoms, and most preferably 16 carbon atoms.
    Type: Grant
    Filed: July 23, 2002
    Date of Patent: June 21, 2005
    Inventors: Pam Fredman, Karsten Buschard
  • Publication number: 20030004115
    Abstract: A method for treatment of a diabetic condition, wherein a therapeutically effective amount of at least one isoform of sulfatide is administered to a patient, wherein said at least one isoform of sulfatide upon administration to the patient affects the sulfatide metabolism in such a way that it results in an increased amount of sulfatide.
    Type: Application
    Filed: July 23, 2002
    Publication date: January 2, 2003
    Inventors: Pam Fredman, Karsten Buschard
  • Patent number: 6492337
    Abstract: The use of glycolipids, in particular galactosylceramide, glucosylceramide and lactosylceramide, and specific catchers therefor (antibodies or lectins), in particular monoclonal antibodies, for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications in an individual and for use in the production of pharmaceutical preparations for treatment of said conditions is disclosed.
    Type: Grant
    Filed: September 21, 2000
    Date of Patent: December 10, 2002
    Assignee: A+ Science AB
    Inventors: Pam Fredman, Karsten Buschard
  • Publication number: 20020034769
    Abstract: A complex of a water-soluble polymer containing hydrophobic regions and native sulfatide is disclosed. The complex may be used in assaying methods.
    Type: Application
    Filed: June 15, 2001
    Publication date: March 21, 2002
    Inventors: Karsten Buschard, Pam Fredman, Jan-Eric Mansson
  • Patent number: 6352831
    Abstract: A complex between a water-soluble polymer containing hydrophobic regions and a glycolipid, immunoassays utilizing the complex as an immune reagent and diagnostic methods to be used in the context of neuropathy and insulin-dependent diabetes. The diagnostic methods employ anti-glycolipid antibody as a marker. The preferred glycolipid is sulfatide.
    Type: Grant
    Filed: May 12, 1999
    Date of Patent: March 5, 2002
    Assignee: A+ Science Invest AB
    Inventors: Karsten Buschard, Pam Fredman, Jan-Eric MÃ¥nsson
  • Patent number: 5827828
    Abstract: Methods for the treatment of prediabetes or diabetes in an individual comprise administering to the individual a therapeutically active agent comprising a glycolipid having a galactose-3-O-sulfate moiety capable of binding to islet cell antibodies. Methods of detecting or quantifying islet cell antibodies in a sample, methods for the detection of Langerhans islet cells, methods for monitoring the development of prediabetes, diabetes or symptoms thereof in an individual and methods for prophylactic treatment against the development of prediabetes or diabetes also involve the use of a glycolipid having a galactose-3-O-sulfate moiety.
    Type: Grant
    Filed: February 28, 1995
    Date of Patent: October 27, 1998
    Assignee: A.sup.+ Science Invest AB
    Inventors: Karsten Buschard, Pam Fredman